LAVA Therapeutics (LVTX) Institutional Ownership $1.28 -0.04 (-3.03%) As of 02:31 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for LAVA Therapeutics (NASDAQ:LVTX)Number ofInstitutional Buyers(last 12 months)7TotalInstitutional Inflows(last 12 months)$4.66MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$773.17K Get LVTX Insider Trade Alerts Want to know when executives and insiders are buying or selling LAVA Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LVTX Institutional Buying and Selling by Quarter LAVA Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/14/2025 Bruce & Co. Inc.521,874$663K0.2%-32.4%1.984% 5/13/2025 Lepercq De Neuflize Asset Management LLC23,000$29K0.0%N/A0.087% 5/8/2025 XTX Topco Ltd24,307$31K0.0%N/A0.092% 5/7/2025 BML Capital Management LLC1,960,610$2.49M1.9%N/A7.453% 2/17/2025 Two Sigma Investments LP48,772$46K0.0%-52.5%0.186% 2/17/2025 Sanofi1,919,455$1.83M1.0%N/A7.301% 2/17/2025 Sphera Funds Management LTD.126,328$120K0.0%-13.7%0.481% 2/17/2025 BNP Paribas Financial Markets41,800$40K0.0%N/A0.159% 11/20/2024 Virtu Financial LLC19,103$32K0.0%N/A0.075% 11/15/2024 Sphera Funds Management LTD.146,457$243K0.0%-60.2%0.000% Get the Latest News and Ratings for LVTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for LAVA Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/14/2024 Walleye Capital LLC14,762$25K0.0%-42.5%0.000% 10/8/2024 Pathway Financial Advisors LLC102,500$170K0.0%+70.8%0.404% 8/12/2024 XTX Topco Ltd30,807$55K0.0%N/A0.122% 7/24/2024 Pathway Financial Advisors LLC60,000$108K0.0%+328.6%0.000% 4/10/2024 Pathway Financial Advisors LLC14,000$47K0.0%N/A0.000% 5/12/2023 Bruce & Co. Inc.671,874$1.12M0.3%+571.9%2.650% 2/10/2023 PNC Financial Services Group Inc.50,000$175K0.0%N/A0.197% 2/1/2023 Bank of Montreal Can89,600$530K0.0%N/A0.353% 11/14/2022 UBS Oconnor LLC75,000$343K0.0%N/A0.296% 10/28/2022 Silverarc Capital Management LLC610,809$2.79M0.9%N/A2.409% 8/16/2022 DAFNA Capital Management LLC128,335$379K0.1%-7.9%0.506% 8/15/2022 Nantahala Capital Management LLC322,980$953K0.0%-3.3%1.274% 2/14/2022 Point72 Asset Management L.P.119,152$655K0.0%-3.8%0.470% 11/15/2021 Point72 Asset Management L.P.123,911$734K0.0%N/A0.489% 11/15/2021 AXA S.A.229,121$1.36M0.0%+3.8%0.904% 11/12/2021 Falcon Edge Capital LP140,229$830K0.1%-3.2%0.553% 8/17/2021 Woodline Partners LP86,904$946K0.0%-23.3%0.343% 8/17/2021 Millennium Management LLC138,831$1.51M0.0%-38.6%0.548% 8/16/2021 Redmile Group LLC2,816,196$30.64M0.5%-0.3%11.108% 8/13/2021 Geode Capital Management LLC12,997$141K0.0%N/A0.051% 8/11/2021 Bank of New York Mellon Corp25,288$275K0.0%-26.3%0.100% 8/10/2021 Nicholas Investment Partners LP781,867$8.51M0.5%-4.0%3.084% 8/2/2021 New York State Common Retirement Fund19,136$208K0.0%-26.3%0.075% 5/27/2021 Davidson Kempner Capital Management LP2,000$30K0.0%N/A0.008% 5/18/2021 Millennium Management LLC226,205$3.44M0.0%N/A0.892% 5/18/2021 Point72 Asset Management L.P.5,561$84K0.0%N/A0.022% 5/18/2021 Tudor Investment Corp Et Al19,614$298K0.0%N/A0.077% 5/18/2021 Redmile Group LLC2,824,409$42.90M0.6%N/A11.141% 5/18/2021 Davidson Kempner Capital Management LP2,000$30K0.0%N/A0.008% 5/18/2021 Citadel Advisors LLC60,442$918K0.0%N/A0.238% The DOJ Just Said Your Money Isn’t Yours (Ad)What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.Get your free guide now by clicking here >>5/18/2021 Falcon Edge Capital LP150,454$2.29M0.1%N/A0.593% 5/17/2021 Point72 Hong Kong Ltd9,355$142K0.0%N/A0.037% 5/17/2021 Woodline Partners LP113,242$1.72M0.0%N/A0.447% 5/17/2021 Caas Capital Management LP30,000$456K0.0%N/A0.118% 5/17/2021Pinz Capital Management LP25,900$393K0.1%N/A0.102% 5/17/2021 Sphera Funds Management LTD.213,894$3.25M0.2%N/A0.844% 5/17/2021 Novo Holdings A S3,327,312$50.54M2.1%N/A13.124% 5/14/2021 Nantahala Capital Management LLC381,227$5.79M0.2%N/A1.504% 5/14/2021 Nicholas Investment Partners LP814,840$12.38M0.9%N/A3.214% 5/14/2021 Monashee Investment Management LLC265,000$3.02M0.5%N/A1.045% 5/13/2021 Bank of New York Mellon Corp34,319$521K0.0%N/A0.135% 5/12/2021 Pura Vida Investments LLC54,000$820K0.0%N/A0.213% (Data available from 1/1/2016 forward) LVTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LVTX shares? During the previous two years, 11 institutional investors and hedge funds held shares of LAVA Therapeutics. The most heavily invested institutionals were BML Capital Management LLC ($2.49M), Sanofi ($1.83M), Bruce & Co. Inc. ($663K), Pathway Financial Advisors LLC ($170K), Sphera Funds Management LTD. ($120K), Two Sigma Investments LP ($46K), and BNP Paribas Financial Markets ($40K).Learn more on LVTX's institutional investors. Which institutional investors have been buying LAVA Therapeutics stock? The following institutional investors have purchased LAVA Therapeutics stock in the last 24 months: BML Capital Management LLC ($1.96M), Sanofi ($1.92M), Pathway Financial Advisors LLC ($102.50K), XTX Topco Ltd ($55.11K), BNP Paribas Financial Markets ($41.80K), Lepercq De Neuflize Asset Management LLC ($23K), and Virtu Financial LLC ($19.10K). How much institutional buying is happening at LAVA Therapeutics? Institutional investors have bought a total of 4,121,582 shares in the last 24 months. This purchase volume represents approximately $4.70M in transactions. Which LAVA Therapeutics major shareholders have been selling company stock? The following institutional investors have sold LAVA Therapeutics stock in the last 24 months: Bruce & Co. Inc. ($250K), Sphera Funds Management LTD. ($241.25K), Two Sigma Investments LP ($53.99K), and Walleye Capital LLC ($10.91K). How much institutional selling is happening at LAVA Therapeutics? Institutional investors have sold a total of 556,161 shares in the last 24 months. This volume of shares sold represents approximately $773.17K in transactions. Related Companies ADC Therapeutics Major Shareholders Larimar Therapeutics Major Shareholders Editas Medicine Major Shareholders Greenwich LifeSciences Major Shareholders Protara Therapeutics Major Shareholders scPharmaceuticals Major Shareholders Lyell Immunopharma Major Shareholders Tonix Pharmaceuticals Major Shareholders Fate Therapeutics Major Shareholders Theratechnologies Major Shareholders This page (NASDAQ:LVTX) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredWashington Is Broke—and Eyeing Your Savings NextWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LAVA Therapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Share LAVA Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
